Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion type Assertion NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_head.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion description "[Therefore, AKT3 targeting might be a new promising strategy for therapy of ErbB2(+)/ER?(-) breast cancer and might further increase the responsiveness to an endocrine therapy approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion evidence source_evidence_literature NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion SIO_000772 24463007 NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion wasDerivedFrom befree-2016 NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.
- NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_assertion wasGeneratedBy ECO_0000203 NP1148569.RAFmhNOxBAa6_oqNwWet6A72WpFHpIyZ5dBmdWrdOoC1o130_provenance.